NHTherAguix is a clinical-stage company developing a nanodrug technology platform. Its lead product candidate Aguix maximizes the efficacy of radiotherapy in cancer treatment. Aguix combines imaging and radiosensitization properties through an Intravenous injection.
Axoltis pharma is a biopharmaceutical company dedicated to develop drugs for neurological disorders.
Its vocation is to develop first-in-class disease-modifying drugs to treat patients with neurodegenerative or traumatic disorders with high unmet medical needs.
“BCIP Consulting has helped us having a clear understanding of the status of our exclusivity potential. Starting from this initial diagnostic, BCIP consulting has worked with us to sharpen our IP strategy going forward.” Yann Godfrin, CEO Axoltis pharma
Healshape is a regenerative medicine biotech startup developing products for breast reconstruction and augmentation. Healshape technology relies on a patent on skin biofabrication and strong expertise in bioprinting and tissue engineering.
ERYTECH is a clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases. Leveraging its proprietary ERYCAPS platform, which uses a novel technology to encapsulate therapeutic drug substances inside red blood cells, ERYTECH has developed a pipeline of product candidates targeting markets with high unmet medical needs.